Quinuclidine derivatives and their use as M3 antagonists

Details for Australian Patent Application No. 2002238471 (hide)

International Classifications

Event Publications

23 January 2003 Application Open to Public Inspection

Published as AU-B-2002238471

28 June 2007 Application Accepted

Published as AU-B-2002238471

25 October 2007 Standard Patent Sealed

14 February 2008 Alteration of Name

The name of the patentee has been altered to Almirall AG

24 December 2009 Assignment Registered

Almirall AG The patent has been assigned to Almirall, S.A.

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.